Literature DB >> 6269135

The use of gamma-linolenic acid and linoleic acid to differentiate between temporal lobe epilepsy and schizophrenia.

K S Vaddadi.   

Abstract

Three long-stay, hospitalised schizophrenics who had failed to respond adequately to conventional drug therapy were treated with gamma-linolenic acid and linoleic acid in the form of evening primrose oil. They became substantially worse and electroencephalographic features of temporal lobe epilepsy became apparent. In all three the clinical state dramatically improved when carbamazepine, the conventional therapy for temporal lobe epilepsy was introduced. It can be extremely difficult to distinguish on clinical grounds between schizophrenia and temporal lobe epilepsy, and electroencephalographic studies do not always reveal an abnormality in the temporal lobe syndrome, unless additional procedure such as sphenoidal electroencephalography is undertaken. A trial of therapy with gamma-linolenic acid may prove of considerable value in distinguishing between these two states, so allowing specific therapy to be introduced.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6269135     DOI: 10.1016/0161-4630(81)90069-0

Source DB:  PubMed          Journal:  Prostaglandins Med        ISSN: 0161-4630


  5 in total

Review 1.  Drug interactions between herbal and prescription medicines.

Authors:  Elizabeth M Williamson
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Evening primrose oil reducing serum lithium concentration.

Authors:  Mugtaba Osman; Einas Badawi
Journal:  Ther Adv Psychopharmacol       Date:  2016-08-08

3.  Status epilepticus associated with borage oil ingestion.

Authors:  Wafa'a A Al-Khamees; Michael D Schwartz; Saleh Alrashdi; Adam D Algren; Brent W Morgan
Journal:  J Med Toxicol       Date:  2011-06

4.  A controlled trial of prostaglandin E1 precursor in chronic neuroleptic resistant schizophrenic patients.

Authors:  K S Vaddadi; C J Gilleard; R H Mindham; R Butler
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Nutrient- and non-nutrient-based natural health product (NHP) use in adults with mood disorders: prevalence, characteristics and potential for exposure to adverse events.

Authors:  Karen M Davison; Bonnie J Kaplan
Journal:  BMC Complement Altern Med       Date:  2013-04-09       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.